Both in Pharmaceuticals
Boundless Bio vs Heron Therapeutics
Over the past year BOLD returned +76.6% and HRTX returned −75.5%; their daily moves had a correlation of 0.04.
BOLD +76.6% HRTX −75.5%Growth of $1, one year, split-adjusted
| Metric | BOLD | HRTX |
|---|---|---|
| Price | $2.42 | $0.2887 |
| Market cap | $55.9M | $54.8M |
| Today | −0.82% | −2.17% |
| 1 month | −6.9% | −22.0% |
| 6 months | +54.1% | −76.5% |
| Year to date | +101.7% | −77.8% |
| 1 year | +72.9% | −75.1% |
| Revenue growth (YoY) | — | +1.3% |
| Gross margin | — | 69.3% |
| Net margin | — | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $72.6M | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | 31.5% | 87.5% |
| Short % of float | 7.0% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).